ResearcherZhengzhou UniversityNo recent work listed
Guoqiang Zhao
Matched on ORCID iD 0000-0002-5257-5637; OpenAlex author ID A5102017348. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2014: 3 papers · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper
Papers 5
- Retraction Note: miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer. Last author DOI 10.1186/s12943-019-1042-y↗
- miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer. Last author DOI 10.1186/s12943-015-0315-3↗
- MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2. Co-author DOI 10.1007/s13277-013-1115-2↗
- Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients. Last author DOI 10.1186/1746-1596-9-61↗
- miR-337 regulates the proliferation and invasion in pancreatic ductal adenocarcinoma by targeting HOXB7. Last author DOI 10.1186/s13000-014-0171-2↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wenqiao Zang · 5 shared papers, 2014–2019 · strength 0.30
- Paper Retraction Note: miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer. DOI 10.1186/s12943-019-1042-y↗
- Paper miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer. DOI 10.1186/s12943-015-0315-3↗
- Paper Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients. DOI 10.1186/1746-1596-9-61↗
- Min Li · 2 shared papers, 2014–2019 · strength 0.15
- Tao Wang · 1 shared paper, 2015 · strength 0.06
- Min Li · 1 shared paper, 2015 · strength 0.06
- Rui Zhang · 1 shared paper, 2014 · strength 0.05
- Rui Zhang · 1 shared paper, 2014 · strength 0.04
- Ping Li · 1 shared paper, 2014 · strength 0.04
- Rui Zhang · 1 shared paper, 2014 · strength 0.04
- Li Li · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.